Takeda Ventures was joined in the series B round by venture firms Triathlon Medical Venture Partners and New Science Ventures, which co-led the round. The Global Cardiovascular Innovation Center and venture firms

In December, IntegenX raised $40m in series C financing from investors including corporate venturing unit Samsung Ventures and In-Q-Tel, the venture capital (VC) firm supported by the US intelligence community.

Alongside Uni Venture, a venture capital arm of Bawag that works closely with Innovationsagentur, in the round were Buschier, Fides and Hybag.

In 2011, Evotec, Harvard and the Howard Hughes Medical Institute collaborated to analyse and characterise drug candidates identified by scientists at the Harvard University laboratory of Douglas Melton.

The fund plans to raise $100m by the end of the year, according to news provider Asia Venture Capital Journal.

Italy-based medical device company Sorin Group also has an option to acquire the US-based heart treatment company.